These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7496177)
1. A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin. Arikawa-Hirasawa E; Koga R; Tsukahara T; Nonaka I; Mitsudome A; Goto K; Beggs AH; Arahata K Neuromuscul Disord; 1995 Sep; 5(5):429-38. PubMed ID: 7496177 [TBL] [Abstract][Full Text] [Related]
3. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Matsumura K; Campbell KP Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699 [TBL] [Abstract][Full Text] [Related]
4. Expression of dystrophin-associated glycoproteins and utrophin in carriers of Duchenne muscular dystrophy. Sewry CA; Matsumura K; Campbell KP; Dubowitz V Neuromuscul Disord; 1994; 4(5-6):401-9. PubMed ID: 7881285 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin. Matsumura K; Burghes AH; Mora M; Tomé FM; Morandi L; Cornello F; Leturcq F; Jeanpierre M; Kaplan JC; Reinert P J Clin Invest; 1994 Jan; 93(1):99-105. PubMed ID: 8282827 [TBL] [Abstract][Full Text] [Related]
6. Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy. Kawajiri M; Mitsui T; Kawai H; Kobunai T; Tsuchihashi T; Saito S J Neuropathol Exp Neurol; 1996 Aug; 55(8):896-903. PubMed ID: 8759779 [TBL] [Abstract][Full Text] [Related]
7. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene. Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Tachi N; Ohya K; Chiba S; Matsuo M; Patria SY; Matsumura K Neurology; 1997 Aug; 49(2):579-83. PubMed ID: 9270600 [TBL] [Abstract][Full Text] [Related]
9. Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy. Matsumura K; Tomé FM; Collin H; Leturcq F; Jeanpierre M; Kaplan JC; Fardeau M; Campbell KP Neuromuscul Disord; 1994 Mar; 4(2):115-20. PubMed ID: 7516752 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. Jung D; Yang B; Meyer J; Chamberlain JS; Campbell KP J Biol Chem; 1995 Nov; 270(45):27305-10. PubMed ID: 7592992 [TBL] [Abstract][Full Text] [Related]
12. Mosaic expression of two dystrophins in a boy with progressive muscular dystrophy. Rivier F; Tuffery S; Jellali AJ; Echenne B; Mornet D; Pons F Muscle Nerve; 1998 Oct; 21(10):1317-20. PubMed ID: 9736061 [TBL] [Abstract][Full Text] [Related]
13. Preferential subsarcolemmal localization of dystrophin and beta-dystroglycan mRNA in human skeletal muscles. Mitsui T; Kawai H; Shono M; Kawajiri M; Kunishige M; Saito S J Neuropathol Exp Neurol; 1997 Jan; 56(1):94-101. PubMed ID: 8990133 [TBL] [Abstract][Full Text] [Related]
14. A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. Lenk U; Oexle K; Voit T; Ancker U; Hellner KA; Speer A; Hübner C Hum Mol Genet; 1996 Jul; 5(7):973-5. PubMed ID: 8817332 [TBL] [Abstract][Full Text] [Related]
15. Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle. Cullen MJ; Walsh J; Nicholson LV Acta Neuropathol; 1994; 87(4):349-54. PubMed ID: 8017170 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. Mizuno Y; Nonaka I; Hirai S; Ozawa E J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010 [TBL] [Abstract][Full Text] [Related]
17. Interactions between dystrophin and the sarcolemma membrane. Chamberlain JS; Corrado K; Rafael JA; Cox GA; Hauser M; Lumeng C Soc Gen Physiol Ser; 1997; 52():19-29. PubMed ID: 9210217 [TBL] [Abstract][Full Text] [Related]
18. Expression of the 43 kDa dystrophin-associated glycoprotein in human neuromuscular disease. Helliwell TR; Nguyen TM; Morris GE Neuromuscul Disord; 1994 Mar; 4(2):101-13. PubMed ID: 8012191 [TBL] [Abstract][Full Text] [Related]